Companion Animal Drugs Market Trends

Companion Animal Drugs Market Trends

• The rising rate of obesity in companion animals is becoming a significant driver in the market.
   
• According to the Association for Pet Obesity Prevention, the 2022 Pet Obesity Prevalence Survey revealed that 59% of dogs and 61% of cats in the U.S. are classified as overweight or obese. This represents an increase from previous years, with 56% of dogs and 60% of cats being overweight or obese in 2018 and 2017, respectively.
   
• This upward trend in pet obesity is not just a health concern but also a growing market opportunity, as it drives the demand for veterinary medications and treatments.
   
• Furthermore, the growing awareness among pet owners about the health implications of obesity is fueling the demand of drugs used to treat various health conditions related to obesity.
   
• As more pet owners become informed about the risks associated with their pets being overweight, they are more likely to seek professional veterinary care and purchase medications to address these issues. This proactive approach to pet health is leading to a broader range of products in the market, including innovative treatments that cater specifically to the needs of overweight and obese animals.